Wealth Enhancement Advisory Services
NNVC icon

Wealth Enhancement Advisory Services’s NanoViricides NNVC Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,138
Closed -$25.9K – 3451
2025
Q1 		$25.9K Buy
+22,138
New +$28.1K ﹤0.01% 2900

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Enhancement Advisory Services's NNVC Position: Q2 2025 in Review

Wealth Enhancement Advisory Services sold out of NanoViricides (NNVC) in Q2 2025, closing a stake of 22,138 shares — an estimated $25.9K sold.

Wealth Enhancement Advisory Services first reported a position in NNVC in Q1 2025 and held it in 1 quarter. The position peaked at $25.9K in Q1 2025. 33 funds tracked by Wall St. Rank hold NNVC as of Q2 2025.

  • Wealth Enhancement Advisory Services reported no remaining NanoViricides position as of Q2 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 22,138 NanoViricides shares in Q2 2025, an estimated $25.9K.
  • Wealth Enhancement Advisory Services first reported a position in NanoViricides in Q1 2025 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's NanoViricides position peaked at $25.9K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held NanoViricides as of Q2 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.